Literature DB >> 27601157

Is Africa a 'Graveyard' for Linear Accelerators?

H Reichenvater1, L Dos S Matias2.   

Abstract

Linear accelerator downtimes are common and problematic in many African countries and may jeopardise the outcome of affected radiation treatments. The predicted increase in cancer incidence and prevalence on the African continent will require, inter alia, improved response with regard to a reduction in linear accelerator downtimes. Here we discuss the problems associated with the maintenance and repair of linear accelerators and propose alternative solutions relevant for local conditions in African countries. The paper is based on about four decades of experience in capacity building, installing, commissioning, calibrating, servicing and repairing linear accelerators in Africa, where about 40% of the low and middle income countries in the world are geographically located. Linear accelerators can successfully be operated, maintained and repaired in African countries provided proper maintenance and repair plans are put in place and executed.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Africa; equipment maintenance and repair; linear accelerator; radiation therapy

Mesh:

Year:  2016        PMID: 27601157     DOI: 10.1016/j.clon.2016.08.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

Review 1.  Radiotherapy waiting time in Northern Nigeria: experience from a resource-limited setting.

Authors:  Nuhu Tumba; Sunday Adeyemi Adewuyi; Kelechi Eguzo; Adeniyi Adenipekun; Rasaaq Oyesegun
Journal:  Ecancermedicalscience       Date:  2020-09-04

2.  Radiotherapy treatment in cancer control and its important role in Africa.

Authors:  Ntokozo Ndlovu
Journal:  Ecancermedicalscience       Date:  2019-07-25

3.  Maintenance versus replacement of medical equipment: a cost-minimization analysis among district hospitals in Nepal.

Authors:  Michael Hillebrecht; Constantin Schmidt; Bhim Prasad Saptoka; Josef Riha; Matthias Nachtnebel; Till Bärnighausen
Journal:  BMC Health Serv Res       Date:  2022-08-12       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.